1. Home
  2. ACHC vs EVO Comparison

ACHC vs EVO Comparison

Compare ACHC & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACHC
  • EVO
  • Stock Information
  • Founded
  • ACHC 2005
  • EVO 1993
  • Country
  • ACHC United States
  • EVO Germany
  • Employees
  • ACHC N/A
  • EVO N/A
  • Industry
  • ACHC Medical Specialities
  • EVO Biotechnology: Pharmaceutical Preparations
  • Sector
  • ACHC Health Care
  • EVO Health Care
  • Exchange
  • ACHC Nasdaq
  • EVO Nasdaq
  • Market Cap
  • ACHC 1.7B
  • EVO 1.4B
  • IPO Year
  • ACHC N/A
  • EVO 2021
  • Fundamental
  • Price
  • ACHC $17.94
  • EVO $3.12
  • Analyst Decision
  • ACHC Strong Buy
  • EVO Strong Buy
  • Analyst Count
  • ACHC 12
  • EVO 1
  • Target Price
  • ACHC $34.67
  • EVO $7.00
  • AVG Volume (30 Days)
  • ACHC 2.3M
  • EVO 54.0K
  • Earning Date
  • ACHC 11-05-2025
  • EVO 11-05-2025
  • Dividend Yield
  • ACHC N/A
  • EVO N/A
  • EPS Growth
  • ACHC N/A
  • EVO N/A
  • EPS
  • ACHC 1.18
  • EVO N/A
  • Revenue
  • ACHC $3,265,548,000.00
  • EVO $887,396,457.00
  • Revenue This Year
  • ACHC $7.20
  • EVO N/A
  • Revenue Next Year
  • ACHC $6.65
  • EVO $10.78
  • P/E Ratio
  • ACHC $15.47
  • EVO N/A
  • Revenue Growth
  • ACHC 4.58
  • EVO N/A
  • 52 Week Low
  • ACHC $17.13
  • EVO $2.84
  • 52 Week High
  • ACHC $47.08
  • EVO $5.64
  • Technical
  • Relative Strength Index (RSI)
  • ACHC 20.35
  • EVO 30.80
  • Support Level
  • ACHC $18.32
  • EVO $2.95
  • Resistance Level
  • ACHC $23.77
  • EVO $4.09
  • Average True Range (ATR)
  • ACHC 0.99
  • EVO 0.09
  • MACD
  • ACHC -0.49
  • EVO -0.12
  • Stochastic Oscillator
  • ACHC 1.32
  • EVO 13.43

About ACHC Acadia Healthcare Company Inc.

Acadia Healthcare Co Inc acquires and develops behavioral healthcare facilities. Acute inpatient psychiatric facilities and specialty treatment facilities contribute the vast majority of Acadia's revenue in the United States. The company's revenue is derived from services rendered to patients for inpatient psychiatric and substance abuse care, outpatient psychiatric care, and adolescent residential treatment.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: